Literature DB >> 26449675

Serum acidosis prior to reperfusion facilitates hemodynamic recovery following liver transplantation.

Kyota Fukazawa1, Alexander A Vitin2, Ernesto A Pretto3.   

Abstract

INTRODUCTION: Reperfusion is the most critical event during liver transplantation, and sustained leakage of acidic preservation solution from the liver graft contributes to marked hemodynamic instability. Recent laboratory studies with hepatocyte cultures have revealed that low pH may protect hepatocyte mitochondria against ischemia-reperfusion injury by inhibiting the mitochondrial permeability transition (MPT), the so-called "pH paradox." However, the clinical significance of this pH paradox theory remains largely unknown. In this study, we sought to determine whether there is an association between serum pH immediately prior to reperfusion and hemodynamic recovery after reperfusion and graft survival.
METHODS: We analyzed retrospective data from 527 patients who underwent Orthotopic liver transplantation between 2003 and 2008. All patients were allocated to one of two groups: pH ≤ 7.32 or pH > 7.32, as measured 5 min before reperfusion. Case-control matching was performed using the propensity score to adjust for background differences between the two groups. Data were analyzed using Student's t-test and the χ (2) test.
RESULTS: There were 85 patients in the pH ≤ 7.32 group and 385 patients in the pH > 7.32 group. The recovery of mean arterial pressure after hepatic artery reperfusion was significantly faster in the pH ≤ 7.32 group (slope of recovery: 0.0004 % vs. 0.0002 %/min, p = 0.041). Other parameters studied, including vasopressor dosage after reperfusion, did not show any statistically significant difference between groups.
CONCLUSIONS: Our findings suggest that less aggressive treatment of acidosis with a slower rate of normalization of serum pH (from low to normal) after reperfusion promotes faster hemodynamic stabilization. These findings provide evidence to support the concept of the pH paradox, and may also substantiate the argument against the usage of alkalizing agents before reperfusion unless acidosis becomes clinically significant.

Entities:  

Keywords:  Acidosis; Liver transplantation; Organ transplant; Reperfusion

Mesh:

Substances:

Year:  2015        PMID: 26449675     DOI: 10.1007/s00540-015-2080-2

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  21 in total

1.  Influence of retrograde flushing via the caval vein on the post-reperfusion syndrome in liver transplantation.

Authors:  Kniepeiss Daniela; Zink Michael; Iberer Florian; Schaffellner Silvia; Jakoby Estrella; Duller Doris; Tscheliessnigg Karl-Heinz
Journal:  Clin Transplant       Date:  2004-12       Impact factor: 2.863

2.  Randomized controlled trial to evaluate flush and reperfusion techniques in liver transplantation.

Authors:  J M Millis; J Melinek; M Csete; D K Imagawa; K M Olthoff; G Neelankanta; M Y Braunfeld; M J Sopher; S M Chan; J L Pregler; H Yersiz; A A Busuttil; C R Shackleton; A Shaked; R W Busuttil
Journal:  Transplantation       Date:  1997-02-15       Impact factor: 4.939

3.  A heart mitochondrial Ca2(+)-dependent pore of possible relevance to re-perfusion-induced injury. Evidence that ADP facilitates pore interconversion between the closed and open states.

Authors:  M Crompton; A Costi
Journal:  Biochem J       Date:  1990-02-15       Impact factor: 3.857

4.  Calcium-dependent opening of a non-specific pore in the mitochondrial inner membrane is inhibited at pH values below 7. Implications for the protective effect of low pH against chemical and hypoxic cell damage.

Authors:  A P Halestrap
Journal:  Biochem J       Date:  1991-09-15       Impact factor: 3.857

5.  Sanglifehrin A acts as a potent inhibitor of the mitochondrial permeability transition and reperfusion injury of the heart by binding to cyclophilin-D at a different site from cyclosporin A.

Authors:  Samantha J Clarke; Gavin P McStay; Andrew P Halestrap
Journal:  J Biol Chem       Date:  2002-07-02       Impact factor: 5.157

6.  Modulation of the mitochondrial megachannel by divalent cations and protons.

Authors:  I Szabó; P Bernardi; M Zoratti
Journal:  J Biol Chem       Date:  1992-02-15       Impact factor: 5.157

7.  Reperfusion injury to endothelial cells after cold storage of rat livers: protection by mildly acidic pH and lack of protection by antioxidants.

Authors:  J C Caldwell-Kenkel; R T Currin; A Coote; R G Thurman; J J Lemasters
Journal:  Transpl Int       Date:  1995       Impact factor: 3.782

8.  Modulation of the mitochondrial cyclosporin A-sensitive permeability transition pore. I. Evidence for two separate Me2+ binding sites with opposing effects on the pore open probability.

Authors:  P Bernardi; P Veronese; V Petronilli
Journal:  J Biol Chem       Date:  1993-01-15       Impact factor: 5.157

9.  Protection by pentoxifylline against graft failure from storage injury after orthotopic rat liver transplantation with arterialization.

Authors:  S Bachmann; J C Caldwell-Kenkel; R T Currin; S N Lichtman; R Steffen; R G Thurman; J J Lemasters
Journal:  Transpl Int       Date:  1992       Impact factor: 3.782

Review 10.  The mitochondrial permeability transition: a current perspective on its identity and role in ischaemia/reperfusion injury.

Authors:  Andrew P Halestrap; Andrew P Richardson
Journal:  J Mol Cell Cardiol       Date:  2014-08-30       Impact factor: 5.000

View more
  3 in total

1.  Association of acidosis with coagulopathy and transfusion requirements in liver transplantation.

Authors:  Júlia Ruete de Souza; Ana Paula Yokoyama; Mariana Munari Magnus; Ilka Boin; Elaine Cristina de Ataide; Derli Conceição Munhoz; Fabrício Bíscaro Pereira; Angela Luzo; Fernanda Andrade Orsi
Journal:  J Thromb Thrombolysis       Date:  2021-11-20       Impact factor: 2.300

Review 2.  Pre-conditions for eliminating mitochondrial dysfunction and maintaining liver function after hepatic ischaemia reperfusion.

Authors:  Chenxia Hu; Lanjuan Li
Journal:  J Cell Mol Med       Date:  2017-03-16       Impact factor: 5.310

Review 3.  Perioperative Management of Lactic Acidosis in End-Stage Liver Disease Patient.

Authors:  Alexander A Vitin; Leonard Azamfirei; Dana Tomescu; John D Lang
Journal:  J Crit Care Med (Targu Mures)       Date:  2017-05-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.